The purpose of this study is to determine whether lipoprotein(a), also called Lp(a), is a risk factor for cardiovascular (heart) disease. Lipoproteins are tiny particles that circulate in the blood. They contain cholesterol, fat, and protein in varying amounts depending on the body's need. Higher levels of lipoproteins in the blood can cause an increased risk of heart disease. The investigators believe that by studying the Lp(a) lipoprotein in Caucasians and African Americans, the investigators can assess for genetic variation factors related to cardiovascular (heart) disease. The investigators will be looking at 100 African-American families and 100 Caucasian families to confirm whether a higher Lp(a) level is an indicator of a higher risk for heart disease.
During the study visit the research staff will ask about the medical history, perform a brief physical exam, and draw approximately 4 teaspoons of blood of each family member.
Study Type
OBSERVATIONAL
Enrollment
325
UC Davis CTSC Clinical Research Center (CCRC) at Veterans Affair Medical Center
Mather, California, United States
Genetic variation of Lp(a) levels in each group
Time frame: five years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.